STAGE 4 NSCLC

Clinical trials for STAGE 4 NSCLC explained in plain language.

Never miss a new study

Get alerted when new STAGE 4 NSCLC trials appear

Sign up with your email to follow new studies for STAGE 4 NSCLC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1

New hope for stage 4 lung cancer? trial combines experimental drug with standard therapy

Disease control Not yet recruiting

This study tests whether adding an experimental drug (EIK1001) to standard treatment (pembrolizumab plus chemotherapy) helps people with stage 4 non-small cell lung cancer live longer or stop their cancer from growing. About 750 adults whose cancer has spread will receive either …

Matched conditions: STAGE 4 NSCLC

Phase: PHASE2, PHASE3 • Sponsor: Eikon Therapeutics • Aim: Disease control

Last updated May 11, 2026 20:46 UTC

STAGE 4 NSCLC

Get alerted when new STAGE 4 NSCLC trials appear

New hope for stage 4 lung cancer? trial combines experimental drug with standard therapy